US Stock MarketDetailed Quotes
EQRXW EQRX INC C/WTS (TO PUR COM)
- 0.0455
- 0.00000.00%
Close Nov 9 16:00 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.0455Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.295652wk High0.00P/B0Float Cap0.039152wk Low--Dividend TTM0Shs Float1.8000Historical High--Div YieldTTM0.00%Amplitude0.0391Historical Low--Avg Price1Lot Size
About EQRX INC C/WTS (TO PUR COM) Company
EQRx Inc is a biotechnology company. the company has more than 10 programs in its pipeline, including clinical, preclinical and drug engineering targets for the treatment of oncology and immune-inflammatory conditions. The program includes Aumolertinib, Lerociclib, Sugemalimab, Nofazinlimab, and others.
Company Profile
SymbolEQRXW
Company NameEQRX INC C/WTS (TO PUR COM)
CEOMs. Melanie I. Nallicheri
MarketNASDAQ
Employees363
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Websitehttps://www.eqrx.com
Company Executives
- Name
- Position
- Salary
- Melanie I. Nallicheri
- President, Chief Executive Officer, Principal Financial Officer and Director
- 3.61M
- Alexis A. Borisy, A.M.
- Executive Chairman of the Board
- 4.30M
- Paul L. Berns
- Independent Director
- 2.85K
- Dr. Sandra J. Horning, M.D.
- Independent Director
- 150.92K
- Dr. Amy Abernethy, M.D.,PhD
- Independent Director
- 2.34K
- Samuel J. Merksamer
- Independent Director
- 2.45K
- Kathryn E. Giusti
- Independent Director
- 811.50K
- Dr. Krishna Yeshwant
- Independent Director
- 2.96K
- Dr. Clive A. Meanwell, M.D.,PhD
- Independent Director
- 50.51K
- Jorge Conde
- Independent Director
- --
- Dina Ciarimboli
- General Counsel and Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg